Goldman Sachs
NVAX icon

Goldman Sachs’s Novavax NVAX Stock Holding History

Goldman Sachs’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
1,409,446
+318,887
+29% +$2.89M ﹤0.01% 2951
2025
Q4 		$7.33M Buy
1,090,559
+301,283
+38% +$2.27M ﹤0.01% 3385
2025
Q3 		$6.84M Sell
789,276
-17,385
-2% -$135K ﹤0.01% 3348
2025
Q2 		$5.08M Sell
806,661
-12,599
-2% -$83.4K ﹤0.01% 3396
2025
Q1 		$5.25M Sell
819,260
-138,452
-14% -$1.14M ﹤0.01% 3301
2024
Q4 		$7.7M Buy
957,712
+47,978
+5% +$463K ﹤0.01% 3039
2024
Q3 		$11.5M Sell
909,734
-521,423
-36% -$6.73M ﹤0.01% 2577
2024
Q2 		$18.1M Buy
1,431,157
+494,662
+53% +$4.98M ﹤0.01% 1968
2024
Q1 		$4.48M Buy
936,495
+72,761
+8% +$337K ﹤0.01% 3192
2023
Q4 		$4.15M Buy
863,734
+297,887
+53% +$1.82M ﹤0.01% 3322
2023
Q3 		$4.1M Buy
565,847
+28,956
+5% +$231K ﹤0.01% 3163
2023
Q2 		$3.99M Sell
536,891
-493,950
-48% -$3.88M ﹤0.01% 3299
2023
Q1 		$7.14M Sell
1,030,841
-293,010
-22% -$2.7M ﹤0.01% 2719
2022
Q4 		$13.6M Buy
1,323,851
+362,393
+38% +$6.4M ﹤0.01% 2299
2022
Q3 		$17.5M Buy
961,458
+346,261
+56% +$15M ﹤0.01% 1988
2022
Q2 		$31.6M Buy
615,197
+126,453
+26% +$6.55M 0.01% 1508
2022
Q1 		$36M Buy
488,744
+132,144
+37% +$11.8M 0.01% 1580
2021
Q4 		$51M Sell
356,600
-19,812
-5% -$3.4M 0.01% 1322
2021
Q3 		$78M Sell
376,412
-64,432
-15% -$14.2M 0.02% 908
2021
Q2 		$93.6M Sell
440,844
-324,407
-42% -$59.4M 0.02% 774
2021
Q1 		$139M Buy
765,251
+207,343
+37% +$41.3M 0.04% 493
2020
Q4 		$62.2M Buy
557,908
+312,950
+128% +$33.3M 0.02% 954
2020
Q3 		$26.5M Buy
244,958
+50,220
+26% +$6.12M 0.01% 1518
2020
Q2 		$16.2M Buy
194,738
+18,384
+10% +$703K ﹤0.01% 1851
2020
Q1 		$2.4M Buy
176,354
+142,822
+426% +$1.21M ﹤0.01% 3165
2019
Q4 		$133K Sell
33,532
-2,255
-6% -$9.78K ﹤0.01% 5003
2019
Q3 		$179K Sell
35,787
-1,717
-5% -$9.4K ﹤0.01% 4849
2019
Q2 		$220K Sell
37,504
-36,090
-49% -$284K ﹤0.01% 4745
2019
Q1 		$810K Buy
73,594
+45,912
+166% +$1.45M ﹤0.01% 4173
2018
Q4 		$1.02M Sell
27,682
-2,645
-9% -$103K ﹤0.01% 3963
2018
Q3 		$1.14M Sell
30,327
-2,320
-7% -$65.3K ﹤0.01% 3967
2018
Q2 		$875K Buy
32,647
+10,218
+46% +$345K ﹤0.01% 4160
2018
Q1 		$942K Buy
22,429
+9,012
+67% +$362K ﹤0.01% 4091
2017
Q4 		$333K Sell
13,417
-16,017
-54% -$391K ﹤0.01% 5115
2017
Q3 		$671K Buy
29,434
+6,067
+26% +$136K ﹤0.01% 4884
2017
Q2 		$537K Sell
23,367
-13,073
-36% -$257K ﹤0.01% 5038
2017
Q1 		$933K Buy
36,440
+16,840
+86% +$463K ﹤0.01% 4442
2016
Q4 		$494K Sell
19,600
-9,121
-32% -$266K ﹤0.01% 5071
2016
Q3 		$1.2M Buy
28,721
+10,928
+61% +$1.41M ﹤0.01% 4251
2016
Q2 		$2.59M Sell
17,793
-5,773
-24% -$662K ﹤0.01% 3396
2016
Q1 		$2.43M Buy
23,566
+10,133
+75% +$1.09M ﹤0.01% 3301
2015
Q4 		$2.25M Sell
13,433
-14,569
-52% -$2.24M ﹤0.01% 3523
2015
Q3 		$3.96M Buy
28,002
+17,750
+173% +$3.98M ﹤0.01% 3088
2015
Q2 		$2.28M Sell
10,252
-8,446
-45% -$1.48M ﹤0.01% 3709
2015
Q1 		$3.09M Buy
18,698
+6,564
+54% +$1.07M ﹤0.01% 3362
2014
Q4 		$1.44M Buy
12,134
+5,302
+78% +$554K ﹤0.01% 4188
2014
Q3 		$570K Buy
6,832
+715
+12% +$64.6K ﹤0.01% 5142
2014
Q2 		$565K Sell
6,117
-21,057
-77% -$1.85M ﹤0.01% 5197
2014
Q1 		$2.46M Buy
27,174
+23,193
+583% +$2.59M ﹤0.01% 3780
2013
Q4 		$407K Buy
3,981
+857
+27% +$60.5K ﹤0.01% 5459
2013
Q3 		$197K Buy
3,124
+1,551
+99% +$87.3K ﹤0.01% 5879
2013
Q2 		$64K Buy
+1,573
New +$68.2K ﹤0.01% 5994

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's NVAX Position: Q1 2026 in Review

Goldman Sachs increased its Novavax (NVAX) stake by 29% in Q1 2026, buying an estimated $2.89M and bringing the position to 1,409,446 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

Goldman Sachs first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Goldman Sachs held 1,409,446 shares of Novavax worth $11.5M as of Q1 2026.
  • Goldman Sachs bought 318,887 Novavax shares in Q1 2026, an estimated $2.89M.
  • Novavax made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2951 holding.
  • Goldman Sachs first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Novavax position peaked at $139M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.